These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30545385)

  • 21. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.
    Koehler EM; Schouten JN; Hansen BE; Hofman A; Stricker BH; Janssen HL
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1201-4. PubMed ID: 23353640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
    Atsawarungruangkit A; Chenbhanich J; Dickstein G
    World J Gastroenterol; 2018 Aug; 24(32):3663-3670. PubMed ID: 30166861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship of visceral adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea].
    Qi J; Lin Q; Lin X; Chen X
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(42):3420-3. PubMed ID: 26813130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population.
    Xie F; Zhou H; Wang Y
    Lipids Health Dis; 2019 Sep; 18(1):170. PubMed ID: 31511022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell distribution width as a non-invasive marker for the assessment of inflammation in non-alcoholic steatohepatitis.
    Dogan S; Celikbilek M; Zararsiz G; Deniz K; Sivgin S; Guven K; Gursoy S; Ozbakir O; Yucesoy M
    Hepatogastroenterology; 2015; 62(138):393-8. PubMed ID: 25916070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].
    Clemente AP; Netto BD; de Carvalho-Ferreira JP; da Silveira Campos RM; de Piano Ganen A; Tock L; de Mello MT; Dâmaso AR
    Rev Paul Pediatr; 2016; 34(1):47-55. PubMed ID: 26830602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
    Sonmez A; Nikolic D; Dogru T; Ercin CN; Genc H; Cesur M; Tapan S; Karslioğlu Y; Montalto G; Banach M; Toth PP; Bagci S; Rizzo M
    J Clin Lipidol; 2015; 9(4):576-82. PubMed ID: 26228676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.
    Omagari K; Kadokawa Y; Masuda J; Egawa I; Sawa T; Hazama H; Ohba K; Isomoto H; Mizuta Y; Hayashida K; Murase K; Kadota T; Murata I; Kohno S
    J Gastroenterol Hepatol; 2002 Oct; 17(10):1098-105. PubMed ID: 12201871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
    Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.
    Pei D; Hsia TL; Chao TT; Lin JD; Hsu CH; Wu CZ; Hsieh CH; Liang YJ; Chen YL
    Saudi J Gastroenterol; 2015; 21(3):158-64. PubMed ID: 26021775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
    Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
    Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity.
    Kim SH; Park HY; Lee HS; Jung KS; Lee MH; Jhee JH; Kim TH; Lee JE; Kim HJ; Kim BS; Park HC; Lee BK; Choi HY
    Sci Rep; 2020 Jan; 10(1):1025. PubMed ID: 31974458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
    Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S
    Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.
    Popov VB; Thompson CC; Kumar N; Ciarleglio MM; Deng Y; Laine L
    Dig Dis Sci; 2016 Sep; 61(9):2477-87. PubMed ID: 27207181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction.
    Cantero I; Abete I; Monreal JI; Martinez JA; Zulet MA
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28657604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.